Skip to main content

Peak Bio, Inc.

PKBODelisted Mar 3, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001834645

Peak Bio, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Dec 4, 2024; 9 institutions reported holding it in 13F filings for Q4 2022, worth $2.53M in total; no superinvestor held it.

13F holders, Q4 2022

Institutional positions in Peak Bio, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

PKBO is no longer listed, so this page shows Q4 2022. 13F filings for later quarters list far fewer holders.

Institutional holders
9
+8 vs. Q3 2022
Shares held
619.6K
+616.6K (+20,551.9%) vs. Q3 2022
Total value
$2.53M
+$2.50M (+8,345.9%) vs. Q3 2022
New holders
9
0 more added
Sold out
1
0 more reduced

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PKBO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 9 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 1 institutionQ4 2022: 9 institutionsQ1 2023: 1 institutionQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2022: $2.53M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $30.0KQ4 2022: $2.53MQ1 2023: $314.1KQ2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding PKBO and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20231$314.1K
Q4 20229$2.53M
Q3 20221$30.0K
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Peak Bio, Inc.; share changes are against Q3 2022.

Institutions holding PKBO in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Palo Alto Investors LP497,528$2.02M0.17%+497,528New
Geode Capital Management, LLC51,092$214.0K0.00%+51,092New
Charles Schwab Investment Management Inc38,631$161.9K0.00%+38,631New
Northern Trust Corp14,382$60.3K0.00%+14,382New
Goldman Sachs Group Inc13,716$57.5K0.00%+13,716New
Tower Research Capital LLC (TRC)3,161$14.0K0.00%+3,161New
UBS Group AG719$3.01K0.00%+719New
Morgan Stanley278$1.17K0.00%+278New
Wells Fargo & Company49$2050.00%+49New
Public Employees Retirement System of Ohio0$00.00%−3,000−100.0%Sold out